|
|
| Source: Business Wire 08-09-2023 06:00:09 |  Motif Neurotech, a clinical-stage company developing minimally invasive bioelectronics for mental health, announces the appointment of Steven Goetz as Chief Technology Officer. Goetz joins Motif after more than 26 years in the Neuromodulation Operating Unit at Medtronic, where he led engineering and innovation initiatives for implantable device therapies for a wide range of diseases.
Read All |
| | | | | | | | |
|
